Effect of thrombolysis (streptokinase) on left ventricular function during acute myocardial infarction

Insights

Successful reperfusion after acute myocardial infarction significantly improves left ventricular function. Early left ventricular ejection fraction is a key predictor of recovery, regardless of thrombolysis timing or infarct location.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Acute myocardial infarction (AMI) poses a significant threat to left ventricular (LV) function.
  • Thrombolytic therapy is a cornerstone in managing AMI, aiming to restore coronary blood flow.
  • Assessing changes in LV function post-thrombolysis is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the impact of successful coronary reperfusion on left ventricular (LV) function in patients with acute myocardial infarction.
  • To determine factors influencing the recovery of LV ejection fraction (EF) after thrombolytic therapy.

Main Methods:

  • Prospective trial involving 192 patients with AMI treated with intracoronary or intravenous streptokinase.
  • First-pass radionuclide ejection fraction (EF) measured early (within 24 hours) and late (10-14 days) post-admission.
  • Analysis of factors including time to lysis, infarct location, and initial ECG findings on EF change.

Main Results:

  • In patients with successful reperfusion (n=68), mean EF increased from 39% to 47%.
  • Patients with unsuccessful reperfusion (n=36) showed a smaller EF increase (38% to 42%).
  • No significant influence of time to lysis, infarct location, or Q waves on the extent of EF change was observed.

Conclusions:

  • Successful reperfusion significantly enhances left ventricular ejection fraction in AMI patients.
  • Initial left ventricular ejection fraction is the primary predictor of subsequent functional improvement.
  • Thrombolysis effectiveness in improving LV function is primarily linked to successful reperfusion rather than specific treatment parameters like timing or infarct location.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...